Clinical Trials Environment Safety Topical 
Cannabis Law Report
MARCH 1, 2022
A fast-paced environment where you’ll work on a wide range of topics. Focus will be on IND/CTA filings and associated interactions, and may include safety reports, protocols, information amendments, responses to requests for information, IND Annual Reports/DSURs, and new investigator amendments. Position: Full-time.
Cannabis Law Report
OCTOBER 2, 2021
A fast-paced environment where you’ll work on a wide range of topics. Focus will be on IND/CTA filings and associated interactions, and may include safety reports, protocols, information amendments, responses to requests for information, IND Annual Reports/DSURs, and new investigator amendments. San Diego, United States.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PrestoDoctor
OCTOBER 11, 2023
For years, the use of cannabis has been a controversial topic. These behaviors may include repetitive movements, specific routines or rituals, intense interests in certain topics, and a resistance to change. Recognizing and understanding these strengths can foster a more inclusive and supportive environment for individuals with ASD.
Cannabis Law Report
JANUARY 19, 2022
He played a leadership role in the areas of defense, health, and the environment. We look forward to his guidance in helping us bring new, THC-based investigational medications into FDA approved clinical trials. He served on the Appropriation, Banking and Finance and Budget committees. www.igcinc.us , www.igcpharma.com.
United Patients Group
MARCH 24, 2023
But among the various topics the Amazonian brew touches, its relationship with depressive disorders is especially noteworthy. This approach allows individuals to confront their emotional and psychological distress in a safe, supportive environment. It encourages introspection, self-reflection, and emotional catharsis.
SpeedWeed
MARCH 18, 2021
million grant from the Colorado Department of Public Health and Environment (CDPHE) to the Multidisciplinary Association of Psychedelic Studies (MAPS). Given the topical nature of the current trial and its relevance for public policy on medical cannabis, participants might have been biased to report positive effects regardless of condition.
The Blunt Truth
AUGUST 13, 2019
CBD is “thriving” in the current regulatory environment, but is it doing so illegally? On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. As former U.S. The FDA needs to act.” First, Sens.
Expert insights. Personalized for you.
52 
Let's personalize your content